SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-22-028277
Filing Date
2022-05-11
Accepted
2022-05-11 16:15:48
Documents
2
Period of Report
2022-05-04

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 8931
2 EX-24 DOCUMENT attachment1.htm EX-24 2739
  Complete submission text file 0001209191-22-028277.txt   13353
Mailing Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054
Business Address 5401 WEST KENNEDY BOULEVARD SUITE 890 TAMPA FL 33609 813-553-6680
Pacira BioSciences, Inc. (Issuer) CIK: 0001396814 (see all company filings)

IRS No.: 510619477 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PACIRA BIOSCIENCES, INC. 5 SYLVAN WAY, SUITE 300 PARSIPPANY NJ 07054
Business Address
GAUGLER DARYL (Reporting) CIK: 0001928278 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35060 | Film No.: 22913905